In this report, we described PBIMA (WES and Proteomic) data for Progressive CNS Inflammation Autoimmune Disease.
as a self-antigen one way to increase ACAN production is by inhibition of ADAMTS4 / 5 metalloproteases that specifically degrade ACAN.
IL6R:
This gene encodes a subunit of the interleukin 6 (IL6) receptor complex. Interleukin 6 is a potent pleiotropic cytokine that regulates cell growth and differentiation and plays an important role in the immune response. The IL6 receptor is a protein complex consisting of this protein and interleukin 6 signal transducer (IL6ST/GP130/IL6beta), a receptor subunit also shared by many other cytokines. In healthy controls, we observed lower levels of the sTNF-RII in carriers of the TT genotype compared to TG/GG genotype (p = 0.04).
In RA there was the same behaviour between TT and TG/GG carriers, even though the difference was not statistically significant (PMID 15603867). Julie has rs1061622-GG genotype. In the OSLO population, 124 (22.7%) subjects were hetero-or homozygote for the rare C allele. Individuals carrying the polymorphism had significantly higher levels of sgp130. In a multivariate linear regression model this association remained significant (adjusted p=0.001). In the VIENNA population, 48 (16.1%) subjects were hetero-or homozygote for the rare C allele. Consistent with the former study, sgp130 levels were significantly higher in carriers of the polymorphism compared to wildtype carriers (adjusted p=0.038). In the VIENNA population, sgp130 levels were significantly higher in diabetic patients. In the OSLO population, sgp130 was higher in patients with increased body mass index and in smokers (p<0.05). In conclusion, this is the first study to report a significant association between the gp130 polymorphism G148C (rs3729960) and 
